Vedang Murthy, MD, DNB, DipEPP, is a Professor and Radiation Oncologist at Tata Memorial Hospital, Mumbai, a premier oncology centre in Asia. Dr Murthy’s area of expertise is in Urological Cancer. He has special interest in high precision radiotherapy procedures such as Image Guided Radiotherapy and Adaptive Radiotherapy. Dr. Murthy did his training in Radiation Oncology from Tata Memorial Hospital and The Royal Marsden NHS Foundation Hospital, London . He also undertook a Diploma in Epidemiology and Biostatistics from the London School of Health and Tropical Medicine. He has over 200 publications in peer reviewed international journals.
Dr Murthy is the Convenor of Uro Oncology at Tata Hospital and currently running several investigator initiated clinical trials including randomised controlled trials in prostate and bladder cancer and is a part of international co-operative groups in GU Oncology. The main areas of interest within GU oncology are high risk prostate cancer, SBRT for prostate and kidney cancer, oligometastatic prostate cancer, bladder preservation and adjuvant radiotherapy in bladder cancer.